ALQA - Alliqua BioMedical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue-16,29412,1774,786.131
Cost of Revenue-8,1445,2273,270.955
Gross Profit-8,1506,9501,515.176
Operating Expenses
Research Development-859715715
Selling General and Administrative-35,32534,34026,155.008
Non Recurring----
Others----
Total Operating Expenses-44,32840,28229,425.963
Operating Income or Loss--28,034-28,105-24,639.832
Income from Continuing Operations
Total Other Income/Expenses Net-10,089-5,720-830-791.603
Earnings Before Interest and Taxes--28,034-28,105-24,639.832
Interest Expense--2,541-1,565-0.384
Income Before Tax--33,754-28,935-25,431.435
Income Tax Expense--715-1,71814
Minority Interest----
Net Income From Continuing Ops--33,039-27,217-25,445.435
Non-recurring Events
Discontinued Operations-4,7961,2001,200
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--28,243-26,017-25,445.435
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--28,243-26,017-25,445.435